Silence Therapeutics (SLN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Silence Therapeutics

    NASDAQ: SLN · Real-Time Price · USD
    5.00
    -0.20 (-3.85%)
    At close: Oct 03, 2025, 3:59 PM
    5.08
    1.60%
    After-hours: Oct 03, 2025, 04:24 PM EDT

    Silence Therapeutics Income Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 43.26M 25.38M 17.5M 12.41M
    Cost of Revenue
    		 11.81M 10.32M 10.88M 7.46M
    Gross Profit
    		 31.45M 15.06M 6.62M 4.96M
    Operating Income
    		 -63.32M -49.6M -48.59M -45.81M
    Interest Income
    		 4.47M 1.45M 226K 10K
    Pretax Income
    		 -44.46M -50.31M -47.37M -45.86M
    Net Income
    		 -45.31M -43.27M -40.49M -39.41M
    Selling & General & Admin
    		 26.88M 20.64M 19.61M 20.01M
    Research & Development
    		 67.88M 44.02M 35.6M 30.77M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 94.77M 64.66M 55.21M 50.77M
    Interest Expense
    		 n/a 34K 47K 8K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 106.58M 74.98M 66.09M 58.23M
    Income Tax Expense
    		 845K -7.04M -6.88M -6.45M
    Shares Outstanding (Basic)
    		 47.22M 37.09M 32.19M 29.65M
    Shares Outstanding (Diluted)
    		 47.22M 37.09M 32.19M 29.65M
    EPS (Basic)
    		 -0.99 -1.17 -1.26 -1.32
    EPS (Diluted)
    		 -0.99 -1.17 -1.26 -1.32
    EBITDA
    		 -48.99M -49.78M -47.88M -45.42M
    EBIT
    		 -49.58M -50.28M -47.32M -45.85M
    Depreciation & Amortization
    		 593K 498K 482K 427K

    Add to Watchlist